CLINICAL_TRIALS
trial_result
· 2021-11-01
Clinical Trial Update: Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection [Phase 2]
Summary
Phase 2 clinical trial update on an immune response to a therapeutic HIV vaccine with treatment interruption in acute or recent HIV infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED